LX-2343
LX-2343 is a neuroprotective agent for the treatment of Alzheimer's disease. LX2343 ameliorates cognitive dysfunction in APP/PS1 transgenic mice via both Aβ production inhibition and clearance promotion. LX2-343 dose-dependently decreases Aβ accumulation in HEK293-APPsw and CHO-APP cells,and promotes Aβ clearance in SH-SY5Y cells and primary astrocytes. The anti-amyloid effects of LX2343 are attributed to suppressing JNK-mediated APPThr668 phosphorylation, thus inhibiting APP cleavage on one hand, and inhibiting BACE1 enzymatic activity with an IC₅₀ value of 11.43±0.36 μmol/L, on the other hand.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1154393-01 0.02 mg (E-Coli)
Recombinant Caenorhabditis elegans Uncharacterized protein ZK353.3 (ZK353.3)
Sign In for Pricing
View Details 
MBS1154393-02 0.1 mg (E-Coli)
Recombinant Caenorhabditis elegans Uncharacterized protein ZK353.3 (ZK353.3)
Sign In for Pricing
View Details MBS1154393-03 0.02 mg (Yeast)
Recombinant Caenorhabditis elegans Uncharacterized protein ZK353.3 (ZK353.3)
Sign In for Pricing
View Details 
MBS1154393-04 0.1 mg (Yeast)
Recombinant Caenorhabditis elegans Uncharacterized protein ZK353.3 (ZK353.3)
Sign In for Pricing
View Details MBS1154393-05 0.02 mg (Baculovirus)
Recombinant Caenorhabditis elegans Uncharacterized protein ZK353.3 (ZK353.3)
Sign In for Pricing
View Details MBS1154393-06 0.02 mg (Mammalian-Cell)
Recombinant Caenorhabditis elegans Uncharacterized protein ZK353.3 (ZK353.3)
Sign In for Pricing
View Details